Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

A proteomic study of resistance to deoxycholate-induced apoptosis.

Bernstein H, Payne CM, Kunke K, Crowley-Weber CL, Waltmire CN, Dvorakova K, Holubec H, Bernstein C, Vaillancourt RR, Raynes DA, Guerriero V, Garewal H.

Carcinogenesis. 2004 May;25(5):681-92. Epub 2004 Jan 16.

PMID:
14729586
2.

Deoxycholate, an endogenous tumor promoter and DNA damaging agent, modulates BRCA-1 expression in apoptosis-sensitive epithelial cells: loss of BRCA-1 expression in colonic adenocarcinomas.

Romagnolo DF, Chirnomas RB, Ku J, Jeffy BD, Payne CM, Holubec H, Ramsey L, Bernstein H, Bernstein C, Kunke K, Bhattacharyya A, Warneke J, Garewal H.

Nutr Cancer. 2003;46(1):82-92.

PMID:
12925308
3.

Role of mitochondrial complexes I and II, reactive oxygen species and arachidonic acid metabolism in deoxycholate-induced apoptosis.

Washo-Stultz D, Crowley-Weber CL, Dvorakova K, Bernstein C, Bernstein H, Kunke K, Waltmire CN, Garewal H, Payne CM.

Cancer Lett. 2002 Mar 28;177(2):129-44.

PMID:
11825660
4.

The specific NOS2 inhibitor, 1400W, sensitizes HepG2 cells to genotoxic, oxidative, xenobiotic, and endoplasmic reticulum stresses.

Payne CM, Bernstein H, Bernstein C, Kunke K, Garewal H.

Antioxid Redox Signal. 2001 Oct;3(5):931-6.

PMID:
11761338
5.

The NH2 terminus of titin spans the Z-disc: its interaction with a novel 19-kD ligand (T-cap) is required for sarcomeric integrity.

Gregorio CC, Trombitás K, Centner T, Kolmerer B, Stier G, Kunke K, Suzuki K, Obermayr F, Herrmann B, Granzier H, Sorimachi H, Labeit S.

J Cell Biol. 1998 Nov 16;143(4):1013-27.

6.

Ragweed sensitization alters pulmonary vascular responses to bronchoprovocation in beagle dogs.

Theodorou A, Weger N, Kunke K, Rhee K, Bice D, Muggenberg B, Lemen R.

J Appl Physiol (1985). 1997 Sep;83(3):912-7.

7.

The prophylactic effects of U75412E pretreatment in a smoke-induced lung injury rabbit model.

Wang S, Lantz RC, Chen GJ, Breceda V, Rider E, Hays AM, Parliman G, Tollinger BJ, Robledo RF, Kunke K, Tinajero J, Witten ML.

Pharmacol Toxicol. 1996 Nov;79(5):231-7.

PMID:
8936555
8.

Serum can inhibit reversal of multidrug resistance by chemosensitisers.

Lehnert M, de Giuli R, Kunke K, Emerson S, Dalton WS, Salmon SE.

Eur J Cancer. 1996 May;32A(5):862-7.

PMID:
9081367
9.

An immunopathological study of herpes-associated erythema multiforme.

Zaim MT, Giorno RC, Golitz LE, Kunke KS, Huff JC.

J Cutan Pathol. 1987 Oct;14(5):257-62.

PMID:
3316328
10.

Intraepidermal neutrophilic IgA dermatosis.

Huff JC, Golitz LE, Kunke KS.

N Engl J Med. 1985 Dec 26;313(26):1643-5. No abstract available.

PMID:
3906400
11.

Normal macrophage function in infants receiving Intralipid by low-dose intermittent administration.

Strunk RC, Murrow BW, Thilo E, Kunke KS, Johnson EG.

J Pediatr. 1985 Apr;106(4):640-5.

PMID:
2984397
12.

Intralipid alters macrophage membrane fatty acid composition and inhibits complement (C2) synthesis.

Strunk RC, Kunke KS, Kolski GB, Revsin BK.

Lipids. 1983 Jul;18(7):493-500. No abstract available.

PMID:
6684723
13.
14.
15.

Complement synthesis by guinea pig peritoneal macrophages: failure to detect chemical carcinogens.

Kunke KS, Strunk RC.

J Natl Cancer Inst. 1981 Jan;66(1):141-6.

PMID:
6935455
16.

Lack of requirement for spreading for macrophages to synthesize complement.

Strunk RC, Kunke KS, Musson RA.

J Reticuloendothel Soc. 1980 Nov;28(5):483-93. No abstract available.

PMID:
7441649
17.
18.

Supplemental Content

Support Center